CSOWM PRACTICE QUESTIONS - 2026/27|
EXAM Q&A | BARIATRIC NUTRITION,
PEDIATRICS, WEIGHT MANAGEMENT
124 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
CSOWM PRACTICE QUESTIONS - 2026/27| EXAM Q&A | BARIATRIC NUTRITION, PEDIATRICS,
WEIGHT MANAGEMENT. It contains 124 carefully selected questions that reflect the most current exam content
and testing strategies. Each question is accompanied by a correct answer and a detailed rationale that explains
the underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 124 Questions
Foundations - Application - Csowm 2026/27 Q& A Bariatric Nutrition Pediatrics Weight Management
Bariatric Nutrition Pediatrics Weight Management Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Bariatric Nutrition 1-21 Obesity, Weight, Gastric Bypass, Roux-en-y Gastric, Diabetes
Pediatric Nutrition 22-42 Obesity, Weight, Diabetes, Surgery, Evaluated
Weight Management 43-63 Obesity, Appropriate, Weight, Surgery, Management
Nutritional Assessment 64-84 Obesity, Weight, Management, Treatment, Diabetes
Medical Nutrition Therapy 85-105 Obesity, Combination, Metabolic, Bariatric, Surgery
Behavioral AND 106-124 Obesity, Weight, Pediatric, Likely, Patients
Psychological Aspects OF
Obesity
TOTAL 124 All questions include answers and detailed rationales
,Section A - Bariatric Nutrition
Q1.
In a patient with severe obesity and type 2 diabetes undergoing Roux-en-Y gastric bypass,
which hormonal change is most directly associated with improved glycemic control
before significant weight loss occurs?
A. Increased glucagon-like peptide-1 B. Decreased ghrelin levels
(GLP-1) secretion
C. Increased peptide YY (PYY) release D. Decreased gastric inhibitory peptide
(GIP) response
Correct: A - Increased glucagon-like peptide-1 (GLP-1) secretion
Rationale:Roux-en-Y gastric bypass enhances rapid delivery of nutrients to the distal ileum,
stimulating L-cells to secrete GLP-1, which augments insulin secretion and improves
glycemia before substantial weight loss. Ghrelin reduction and PYY increase contribute to
appetite suppression but not directly to the rapid glycemic improvement. GIP changes are not
consistently associated with the early glycemic benefits.
Why the other answers are wrong:
B. Ghrelin reduction primarily affects appetite, not the immediate glycemic improvement seen
after bypass.
C. PYY mainly induces satiety and does not directly enhance insulin secretion in the early
post-operative period.
D. GIP response is not consistently altered and is not a primary driver of early glycemic
improvement.
Reference: Mechanick, J.I., et al. (2020). Endocrine Practice, 26(Suppl 1).
Q2.
A patient who underwent one-anastomosis gastric bypass presents with persistent
nausea and refractory hypokalemia. Which micronutrient deficiency is most likely to be
overlooked?
A. Thiamine (vitamin B1) B. Vitamin B12
C. Magnesium D. Zinc
Correct: C - Magnesium
Rationale:One-anastomosis gastric bypass can cause bile reflux and malabsorption, leading
to magnesium loss. Hypokalemia is often refractory to potassium replacement if magnesium
deficiency coexists. Thiamine deficiency causes neurological symptoms, B12 deficiency leads
to macrocytic anemia, and zinc deficiency affects taste and immunity, none of which directly
cause refractory hypokalemia.
Page 3
, Section A - Bariatric Nutrition
Why the other answers are wrong:
A. Thiamine deficiency presents with Wernicke's encephalopathy or beriberi, not refractory hypokalemia.
B. Vitamin B12 deficiency manifests as anemia and neuropathy, not electrolyte disturbances.
D. Zinc deficiency causes alopecia and impaired immunity, not refractory hypokalemia.
Reference: Parrott, J., et al. (2017). Surgery for Obesity and Related Diseases, 13(5).
Q3.
Which combination of behavioral strategies has the strongest evidence for long-term
weight maintenance in pediatric obesity management?
A. Family-based behavioral intervention with B. School-based nutrition education with
parent-only sessions and self-monitoring weekly weigh-ins
C. Individual cognitive-behavioral therapy for D. Pharmacotherapy combined with dietary
the child alone counseling
Correct: A - Family-based behavioral intervention with parent-only sessions and
self-monitoring
Rationale:Family-based interventions that include parents as agents of change, with
self-monitoring and behavioral skills training, have the strongest evidence for sustained
weight maintenance in pediatric obesity. School-based education alone lacks intensity,
individual child therapy does not address home environment, and pharmacotherapy is
reserved for severe cases with limited long-term data.
Why the other answers are wrong:
B. School-based programs typically lack the intensity and family engagement needed for
sustained weight maintenance.
C. Individual child therapy without family involvement does not target the home environment,
which is crucial for behavior change.
D. Pharmacotherapy is not first-line in pediatrics and has limited long-term efficacy data.
Reference: Wilfley, D.E., et al. (2017). Obesity, 25(6).
Q4.
According to the 2024 American Gastroenterological Association guidelines, which
anti-obesity medication is recommended as first-line pharmacotherapy for patients with
obesity and nonalcoholic steatohepatitis (NASH)?
A. Semaglutide 2.4 mg weekly B. Orlistat 120 mg three times daily
C. Naltrexone-bupropion extended release D. Phentermine-topiramate extended
release
Correct: A - Semaglutide 2.4 mg weekly
Page 4
EXAM Q&A | BARIATRIC NUTRITION,
PEDIATRICS, WEIGHT MANAGEMENT
124 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
CSOWM PRACTICE QUESTIONS - 2026/27| EXAM Q&A | BARIATRIC NUTRITION, PEDIATRICS,
WEIGHT MANAGEMENT. It contains 124 carefully selected questions that reflect the most current exam content
and testing strategies. Each question is accompanied by a correct answer and a detailed rationale that explains
the underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 124 Questions
Foundations - Application - Csowm 2026/27 Q& A Bariatric Nutrition Pediatrics Weight Management
Bariatric Nutrition Pediatrics Weight Management Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Bariatric Nutrition 1-21 Obesity, Weight, Gastric Bypass, Roux-en-y Gastric, Diabetes
Pediatric Nutrition 22-42 Obesity, Weight, Diabetes, Surgery, Evaluated
Weight Management 43-63 Obesity, Appropriate, Weight, Surgery, Management
Nutritional Assessment 64-84 Obesity, Weight, Management, Treatment, Diabetes
Medical Nutrition Therapy 85-105 Obesity, Combination, Metabolic, Bariatric, Surgery
Behavioral AND 106-124 Obesity, Weight, Pediatric, Likely, Patients
Psychological Aspects OF
Obesity
TOTAL 124 All questions include answers and detailed rationales
,Section A - Bariatric Nutrition
Q1.
In a patient with severe obesity and type 2 diabetes undergoing Roux-en-Y gastric bypass,
which hormonal change is most directly associated with improved glycemic control
before significant weight loss occurs?
A. Increased glucagon-like peptide-1 B. Decreased ghrelin levels
(GLP-1) secretion
C. Increased peptide YY (PYY) release D. Decreased gastric inhibitory peptide
(GIP) response
Correct: A - Increased glucagon-like peptide-1 (GLP-1) secretion
Rationale:Roux-en-Y gastric bypass enhances rapid delivery of nutrients to the distal ileum,
stimulating L-cells to secrete GLP-1, which augments insulin secretion and improves
glycemia before substantial weight loss. Ghrelin reduction and PYY increase contribute to
appetite suppression but not directly to the rapid glycemic improvement. GIP changes are not
consistently associated with the early glycemic benefits.
Why the other answers are wrong:
B. Ghrelin reduction primarily affects appetite, not the immediate glycemic improvement seen
after bypass.
C. PYY mainly induces satiety and does not directly enhance insulin secretion in the early
post-operative period.
D. GIP response is not consistently altered and is not a primary driver of early glycemic
improvement.
Reference: Mechanick, J.I., et al. (2020). Endocrine Practice, 26(Suppl 1).
Q2.
A patient who underwent one-anastomosis gastric bypass presents with persistent
nausea and refractory hypokalemia. Which micronutrient deficiency is most likely to be
overlooked?
A. Thiamine (vitamin B1) B. Vitamin B12
C. Magnesium D. Zinc
Correct: C - Magnesium
Rationale:One-anastomosis gastric bypass can cause bile reflux and malabsorption, leading
to magnesium loss. Hypokalemia is often refractory to potassium replacement if magnesium
deficiency coexists. Thiamine deficiency causes neurological symptoms, B12 deficiency leads
to macrocytic anemia, and zinc deficiency affects taste and immunity, none of which directly
cause refractory hypokalemia.
Page 3
, Section A - Bariatric Nutrition
Why the other answers are wrong:
A. Thiamine deficiency presents with Wernicke's encephalopathy or beriberi, not refractory hypokalemia.
B. Vitamin B12 deficiency manifests as anemia and neuropathy, not electrolyte disturbances.
D. Zinc deficiency causes alopecia and impaired immunity, not refractory hypokalemia.
Reference: Parrott, J., et al. (2017). Surgery for Obesity and Related Diseases, 13(5).
Q3.
Which combination of behavioral strategies has the strongest evidence for long-term
weight maintenance in pediatric obesity management?
A. Family-based behavioral intervention with B. School-based nutrition education with
parent-only sessions and self-monitoring weekly weigh-ins
C. Individual cognitive-behavioral therapy for D. Pharmacotherapy combined with dietary
the child alone counseling
Correct: A - Family-based behavioral intervention with parent-only sessions and
self-monitoring
Rationale:Family-based interventions that include parents as agents of change, with
self-monitoring and behavioral skills training, have the strongest evidence for sustained
weight maintenance in pediatric obesity. School-based education alone lacks intensity,
individual child therapy does not address home environment, and pharmacotherapy is
reserved for severe cases with limited long-term data.
Why the other answers are wrong:
B. School-based programs typically lack the intensity and family engagement needed for
sustained weight maintenance.
C. Individual child therapy without family involvement does not target the home environment,
which is crucial for behavior change.
D. Pharmacotherapy is not first-line in pediatrics and has limited long-term efficacy data.
Reference: Wilfley, D.E., et al. (2017). Obesity, 25(6).
Q4.
According to the 2024 American Gastroenterological Association guidelines, which
anti-obesity medication is recommended as first-line pharmacotherapy for patients with
obesity and nonalcoholic steatohepatitis (NASH)?
A. Semaglutide 2.4 mg weekly B. Orlistat 120 mg three times daily
C. Naltrexone-bupropion extended release D. Phentermine-topiramate extended
release
Correct: A - Semaglutide 2.4 mg weekly
Page 4
